Sign in
4

Changes in Ownership

Guardant Health, Inc. Filed Acc 0001753159-26-000006

Co-Chief Executive Officer gave up 33,066 shares (to pay taxes)

  • Co-Chief Executive Officer disposed of 13,209 shares (other)
  • Co-Chief Executive Officer acquired 13,209 shares (other)
  • Co-Chief Executive Officer acquired 65,244 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Talasaz AmirAli Co-Chief Executive Officer 2026-01-01 Other disposition −13,209 0 D: show line 1 in the form
Talasaz AmirAli Co-Chief Executive Officer 2026-01-01 Other acquisition +13,209 2,096,311 I: show line 2 in the form
Talasaz AmirAli Co-Chief Executive Officer 2026-01-01 Option exercise +38,283 2,134,594 I: show line 3 in the form
Talasaz AmirAli Co-Chief Executive Officer 2026-01-01 Shares withheld for taxes −19,402 $102.14 $1,981,720 2,115,192 I: show line 4 in the form
Talasaz AmirAli Co-Chief Executive Officer 2026-03-13 Option exercise +26,961 2,142,153 I: show line 5 in the form
Talasaz AmirAli Co-Chief Executive Officer 2026-03-13 Shares withheld for taxes −13,664 $85.49 $1,168,135 2,128,489 I: show line 6 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Talasaz AmirAli Co-Chief Executive Officer 2026-01-01 Option exercise · Restricted Stock Units −38,283 77,727 D: show line 7 in the form
Talasaz AmirAli Co-Chief Executive Officer 2026-03-13 Option exercise · Performance-Based Restricted Stock Units −26,961 0 D: show line 8 in the form
Talasaz AmirAli Co-Chief Executive Officer 2026-03-17 Grant or award · Restricted Stock Units +11,268 11,268 D: show line 9 in the form
Talasaz AmirAli Co-Chief Executive Officer 2026-03-17 Grant or award · Restricted Stock Units +101,409 101,409 D: show line 10 in the form
Loading xslF345X05/wk-form4_1773799065.xml…